SEC Form 4 · accession 0001209191-18-009018
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey E Young
Officer — Chief Financial Officer
Period of report
Feb 7, 2018
Accepted (ET)
Feb 9, 2018 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2018 | A | 5,000 | $0.00 | A | 5,000 | D | |
| Common StockF2 | Feb 7, 2018 | F | 1,737 | $8.40 | D | 3,263 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of JNP common stock issued upon partial vesting of a restricted stock unit award that vests upon the compensation committee's certification of the achievement of certain performance/milestone goals.
- F2The total number of shares acquired is net of the number of shares withheld for the payment of taxes.